Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Standard of care chemotherapy regimen
DRUG
2 trials
Sponsors
Gulam Manji
, Washington University School of Medicine
Conditions
Adenocarcinoma of the Gastroesophageal Junction
Gastric Adenocarcinoma
Gastric Cancer
Phase 2
Perioperative Chemo and Pembrolizumab in Gastric Cancer
Completed
NCT02918162
Gulam Manji
Adenocarcinoma of the Gastroesophageal Junction, Gastric Cancer
Start: 2017-11-25
End: 2023-02-28
Updated: 2024-02-15
Pre-operative Adaptive Short Court Radiation Therapy in Gastric Cancer
Terminated
NCT04162665
Washington University School of Medicine
Gastric Adenocarcinoma
Start: 2020-02-14
End: 2024-11-21
Updated: 2025-01-09
Related Papers
Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma
JAMA Oncology
2023-10-19
20 citations
Abstract CT009: Phase II trial of perioperative pembrolizumab plus capecitabine and oxaliplatin followed by adjuvant pembrolizumab for resectable gastric and gastroesophageal junction (GC/GEJ) adenocarcinoma
Cancer Research
2022-06-15
13 citations
A phase II study of chemotherapy and immune checkpoint blockade with pembrolizumab in the perioperative and maintenance treatment of locoregional gastric or GE junction adenocarcinoma.
Journal of Clinical Oncology
2018-02-01
1 citations